About Psylink
Psylink is a company based in Vilnius (Lithuania) founded in 2020 by Laura Martinkute Korsakova and Evaldas Ciplys.. Psylink has raised $583.15 thousand across 1 funding round from investors including CoInvest Capital, FIRSTPICK and BSV Ventures. Psylink operates in a competitive market with competitors including Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Vilnius, Lithuania
- Founders Laura Martinkute Korsakova, Evaldas Ciplys
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$583.15 K (USD)
in 1 rounds
-
Latest Funding Round
$583.15 K (USD), Seed
Jul 29, 2025
-
Investors
CoInvest Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Psylink
Psylink has successfully raised a total of $583.15K through 1 strategic funding round. The most recent funding activity was a Seed round of $583.15 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $583,145
-
First Round
First Round
(29 Jul 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Seed - Psylink | Valuation | CoInvest Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Psylink
Psylink has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include CoInvest Capital, FIRSTPICK and BSV Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A venture capital fund and accelerator for Baltic tech startups.
|
Founded Year | Domain | Location | |
|
Early-stage investments in deep tech and life science are supported by BSV Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Psylink
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Psylink
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Psylink Comparisons
Competitors of Psylink
Psylink operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and AmbioPharm, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
APIs and finished dosage forms are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Psylink
When was Psylink founded?
Psylink was founded in 2020 and raised its 1st funding round 5 years after it was founded.
Where is Psylink located?
Psylink is headquartered in Vilnius, Lithuania.
Who is the current CEO of Psylink?
Laura Martinkute Korsakova is the current CEO of Psylink. They have also founded this company.
Is Psylink a funded company?
Psylink is a funded company, having raised a total of $583.15K across 1 funding round to date. The company's 1st funding round was a Seed of $583.15K, raised on Jul 29, 2025.
What does Psylink do?
Psylink was founded in 2020 as a biotechnology company specializing in therapeutic treatments based on psychedelic drugs. Operations are conducted as a privately held entity with 2-10 employees, located in Vilnius, Lithuania. Focus is directed toward innovative drug development solutions within the psychedelic sector, supporting research and therapeutic applications in mental health and related fields.
Who are the top competitors of Psylink?
Psylink's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Who are Psylink's investors?
Psylink has 3 investors. Key investors include CoInvest Capital, FIRSTPICK, and BSV Ventures.